Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

November 27, 2017 by Alan Khadavi

Auvi-Q 0.1 mg dose approved for infants and children

Auvi-Q 0.1 mg dose was recently approved by the FDA for infants and small children weighing 16.5-33 pounds.  Currently there are only 2 dosages on the market for injectable epinephrine, 0.15 mg and 0.3 mg.  The 0.3 mg dose is for anyone over 66 pounds and 0.15 mg for anyone below it.  There was an unmet need for infants and small children dosing as the 0.15 mg may be too high of a dose.  The Auvi-Q 0.1 mg is a more appropriate dosage for children weighing 16.5-33 pounds.  The needle length for Auvi-Q 0.1 mg is also shorter, reducing the risk of hitting the bone while injecting.  Auvi-Q 0.1 mg should be available in the first half of 2018.

Having an age appropriate dosage for injectable epinephrine is very important now.  Recent changes in guidelines recommend introducing high risk infants as young as 4-6 months, peanut containing foods.  This will help lower food allergy to peanuts, but there is also a higher risk of allergic reactions, known as anaphylaxis.  The most common foods that cause anaphylaxis are peanuts, tree nuts, shellfish, fish, wheat, milk, soy and eggs.

Injectable epinephrine has been in the news often over the last year, first because Mylan which manufactures Epipen and Epipen Jr. were inflating their prices greatly.  Since then, many competitors have come out to compete directly with them for the injectable epinephrine market.  Although in the epinephrine market, Epipen still controls a significant market share.

Why is the Epipen Price so High?

Symjepi a cheaper alternative to Epipen, FDA Approved

EpiPen Failure, can epinephrine injectors improve?

When do I use my Epipen?

If your child falls into the weight range for the Auvi-Q 0.1 mg dosage, speak to your pediatric allergist about whether its appropriate for your son or daughter.

Kaleo Press Release

For information on preventing peanut allergy please read the links below.

How to introduce peanuts in infants

New Peanut Guidelines

In summary Auvi-Q is available in 3 strengths:

16.5-33 pounds (7.5 to 15kg)-0.1 mg

33-66 pounds (15-30kg)-0.15 mg

Above 66 pounds (30kg)-0.3 mg

Filed Under: Anaphylaxis, Blog, Pediatric

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page